> top > docs > PMC:7228307 > spans > 57824-58167 > annotations

PMC:7228307 / 57824-58167 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
1178 144-151 Gene denotes FcγRIIb Gene:2213
1179 85-93 Species denotes patients Tax:9606
1181 233-237 Gene denotes FcγR Gene:2213

LitCovid-PD-FMA-UBERON

Id Subject Object Predicate Lexical cue fma_id
T446 57-60 Body_part denotes IgE http://purl.org/sig/ont/fma/fma62875
T447 116-119 Body_part denotes IgE http://purl.org/sig/ont/fma/fma62875
T448 292-297 Body_part denotes cells http://purl.org/sig/ont/fma/fma68646

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T969 3-4 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T970 144-146 http://purl.obolibrary.org/obo/CLO_0052676 denotes Fc
T971 233-235 http://purl.obolibrary.org/obo/CLO_0052676 denotes Fc
T972 292-297 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T973 313-322 http://purl.obolibrary.org/obo/SO_0000418 denotes signaling

LitCovid-sample-PD-IDO

Id Subject Object Predicate Lexical cue
T247 292-297 http://purl.obolibrary.org/obo/CL_0000000 denotes cells

LitCovid-sample-Enju

Id Subject Object Predicate Lexical cue
T71 0-2 VB denotes be
T72 3-4 DT denotes a
T73 5-16 JJ denotes significant
T74 17-26 NN denotes component
T75 27-29 IN denotes of
T76 30-33 DT denotes the
T77 34-39 JJ denotes rapid
T78 40-53 NN denotes disappearance
T79 54-56 IN denotes of
T80 57-60 NN denotes IgE
T81 61-65 IN denotes from
T82 66-69 DT denotes the
T83 70-81 NN denotes circulation
T84 82-84 IN denotes of
T85 85-93 NNS denotes patients
T86 94-101 VBN denotes treated
T87 102-106 IN denotes with
T88 107-110 DT denotes the
T89 111-119 NN denotes anti‐IgE
T90 120-128 NN denotes XmAb7195
T91 129-139 VBG denotes containing
T92 140-143 DT denotes the
T93 144-151 NN denotes FcγRIIb
T94 152-161 VBG denotes enhancing
T95 162-168 NNP denotes “SELF”
T96 169-182 NNS denotes modifications
T97 182-183 -COMMA- denotes ,
T98 184-186 IN denotes as
T99 187-196 VBN denotes described
T100 197-207 RB denotes previously
T101 210-216 JJ denotes Immune
T102 217-224 NN denotes agonism
T103 225-232 IN denotes through
T104 233-237 NN denotes FcγR
T105 238-249 NN denotes scaffolding
T106 250-259 JJ denotes Agonistic
T107 260-264 NNS denotes mAbs
T108 265-271 VBP denotes induce
T109 272-281 NNS denotes responses
T110 282-284 IN denotes in
T111 285-291 NN denotes target
T112 292-297 NNS denotes cells
T113 298-300 IN denotes by
T114 301-312 VBG denotes stimulating
T115 313-322 NN denotes signaling
T116 323-325 IN denotes of
T117 326-331 PRP-DOLLAR- denotes their
T118 332-341 JJ denotes molecular
R75 T74 T71 arg2Of component,be
R76 T74 T72 arg1Of component,a
R77 T74 T73 arg1Of component,significant
R78 T74 T75 arg1Of component,of
R79 T78 T75 arg2Of disappearance,of
R80 T78 T76 arg1Of disappearance,the
R81 T78 T77 arg1Of disappearance,rapid
R82 T78 T79 arg1Of disappearance,of
R83 T80 T79 arg2Of IgE,of
R84 T80 T81 arg1Of IgE,from
R85 T83 T81 arg2Of circulation,from
R86 T83 T82 arg1Of circulation,the
R87 T83 T84 arg1Of circulation,of
R88 T85 T84 arg2Of patients,of
R89 T85 T86 arg2Of patients,treated
R90 T86 T87 arg1Of treated,with
R91 T90 T87 arg2Of XmAb7195,with
R92 T90 T88 arg1Of XmAb7195,the
R93 T90 T89 arg1Of XmAb7195,anti‐IgE
R94 T90 T91 arg1Of XmAb7195,containing
R95 T93 T91 arg2Of FcγRIIb,containing
R96 T93 T92 arg1Of FcγRIIb,the
R97 T93 T94 arg1Of FcγRIIb,enhancing
R98 T96 T94 arg2Of modifications,enhancing
R99 T96 T95 arg1Of modifications,“SELF”
R100 T94 T97 arg1Of enhancing,","
R101 T94 T98 arg1Of enhancing,as
R102 T99 T98 arg2Of described,as
R103 T99 T100 arg1Of described,previously
R104 T102 T101 arg1Of agonism,Immune
R105 T102 T103 arg1Of agonism,through
R106 T105 T103 arg2Of scaffolding,through
R107 T105 T104 arg1Of scaffolding,FcγR
R108 T107 T106 arg1Of mAbs,Agonistic
R109 T107 T108 arg1Of mAbs,induce
R110 T109 T108 arg2Of responses,induce
R111 T109 T110 arg1Of responses,in
R112 T112 T110 arg2Of cells,in
R113 T112 T111 arg1Of cells,target
R114 T108 T113 arg1Of induce,by
R115 T114 T113 arg2Of stimulating,by
R116 T107 T114 arg1Of mAbs,stimulating
R117 T115 T114 arg2Of signaling,stimulating
R118 T115 T116 arg1Of signaling,of

LitCovid-sample-Pubtator

Id Subject Object Predicate Lexical cue pubann:denotes
1178 144-151 Gene denotes FcγRIIb Gene:2213
1179 85-93 Species denotes patients Tax:9606
1181 233-237 Gene denotes FcγR Gene:2213

LitCovid-sample-sentences

Id Subject Object Predicate Lexical cue
T321 210-249 Sentence denotes Immune agonism through FcγR scaffolding

LitCovid-sample-PD-FMA

Id Subject Object Predicate Lexical cue fma_id
T445 57-60 Body_part denotes IgE http://purl.org/sig/ont/fma/fma62875
T446 116-119 Body_part denotes IgE http://purl.org/sig/ont/fma/fma62875
T447 292-297 Body_part denotes cells http://purl.org/sig/ont/fma/fma68646

LitCovid-sample-PD-GO-BP-0

Id Subject Object Predicate Lexical cue
T132 313-322 http://purl.obolibrary.org/obo/GO_0023052 denotes signaling

LitCovid-sample-GO-BP

Id Subject Object Predicate Lexical cue
T132 313-322 http://purl.obolibrary.org/obo/GO_0023052 denotes signaling

LitCovid-PD-GO-BP

Id Subject Object Predicate Lexical cue
T132 313-322 http://purl.obolibrary.org/obo/GO_0023052 denotes signaling

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T321 210-249 Sentence denotes Immune agonism through FcγR scaffolding